Trump Administration's NIH Nominee Defends Funding Cuts and Outlines Research Vision

SOURCE www.foxnews.com
Dr. Jay Bhattacharya defends Trump's decision to cap indirect research costs at NIH, pledges to focus on research benefiting health outcomes, and emphasizes transparency and embracing dissenting ideas. He also addresses concerns about diversity in research and vaccines.

Key Points

  • Bhattacharya defends Trump's 15% cap on indirect research costs at NIH
  • Pledges to focus on research with direct health benefits and transparency
  • Emphasizes embracing dissenting ideas and promoting meaningful outcomes
  • Agrees with Cassidy on no link between vaccines and autism
  • Supports halting the use of aborted fetal tissue in research

Pros

  • Focus on research directly benefiting health outcomes
  • Commitment to transparency and embracing dissenting ideas
  • Efforts to rid agency's research portfolio of frivolous projects

Cons

  • Concerns about potential impact on minority health research
  • Controversial stance on vaccines and autism linkage
  • Support for halting use of aborted fetal tissue in research